Furthermore, studies have shown that CCL2 is highly expressed in tumor epithelial cells, and many CD14-positive cells are infiltrated in primary tumors, implying that high levels of CCL2 and CD14-positive cells can serve as diagnostic markers for early recurrence of breast cancer [35]. This evidence concerns the gene CD14 and breast carcinoma.